Atlas Trials

ChangE From Any Systemic psoriasiS therapY to Raptiva

Clinical trial NCT00697593 · TERMINATED

Trial details

NCT number
NCT00697593
Sponsor
Merck KGaA, Darmstadt, Germany
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Plaque Psoriasis
Start date
2008-01-01
Primary completion
2009-04-01
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.